v3.25.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
6 Months Ended
Jun. 30, 2025
Accounting Policies [Abstract]  
SCHEDULE OF ACQUIRED EQUITY INTERESTS

 

Name of the MC  Percentage of
Equity Interest
Acquired
   Percentage of
Voting Interest
Held
 
Medical Corporation Shobikai   100%   0%
Medical Corporation Kowakai   100%   0%
Medical Corporation Nasukai   100%   0%
Medical Corporation Aikeikai   100%   0%
Medical Corporation Jukeikai   100%   0%
Medical Corporation Ritz Cosmetic Surgery   100%           0%
SCHEDULE OF LOCAL CURRENCY EXCHANGE RATES

Translation of amounts from local currency of the Company into US$1 has been made at the following exchange rates:

  

  

June 30, 2025

  

June 30, 2024

 
Current JPY:US$1 exchange rate   144.1650    160.8680 
Average JPY:US$1 exchange rate   148.4720    152.1868 
SCHEDULE OF FAIR VALUE ON A RECURRING BASIS

Assets measured at fair value on a recurring basis as of June 30, 2025 and December 31, 2024 are summarized below.

 

                 
Fair Value Measurements as of June 30, 2025
   Quoted
Prices in
Active
Markets for
Identical
Assets
(Level 1)
   Significant
Other
Observable
Inputs
(Level 2)
   Unobservable
Inputs
(Level 3)
   Fair
Value at
June 30,
2025
 
Long-term investments:                    
Equity investments at fair value with readily determinable fair value  $2,971,606                 $2,971,606 
Cryptocurrencies:                    
Bitcoin  $535,882           $535,882 

 

                 
Fair Value Measurements as of December 31, 2024
   Quoted
Prices in
Active
Markets for
Identical
Assets
(Level 1)
   Significant
Other
Observable
Inputs
(Level 2)
   Unobservable
Inputs
(Level 3)
   Fair
Value at
December 31,
2024
 
Long-term investments:                    
Equity investments at fair value with readily determinable fair value  $2,478,531                $2,478,531 
Cryptocurrencies:                    
Bitcoin  $           $